Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Vomiting 5Nausea 5Neoplasms 4Hematologic Neoplasms 4Anorexia 3Multiple Myeloma 2Breast Neoplasms 2Testicular Neoplasms 1Solid Tumor Patients Receiving High Emetic Risk Multi-day Chemotherapy 1Prosthesis Failure 1Opioid-Related Disorders 1Nutrition Disorders 1Neoplasms, Plasma Cell 1Gynecologic Cancer 1Cachexia 1Advanced Cancer 1

Interventions

Cisplatin 9Etoposide 7Bleomycin 6Ifosfamide 5Carboplatin 5Radiotherapy 4Peripheral Blood Stem Cell Transplantation 4Vinblastine 3Cyclophosphamide 3liposomal amphotericin B 2Paclitaxel 2Filgrastim 2sodium thiosulfate 1lerisetron 1Valacyclovir 1Surgical Procedures, Operative 1Ribavirin 1Restraint, Physical 1Palivizumab 1Oxaliplatin 1Olanzapine 1Mycophenolic Acid 1Moxifloxacin 1Magnetic Resonance Spectroscopy 1Levofloxacin 1Itraconazole 1Granisetron 1Fluconazole 1Fentanyl 1Cyproheptadine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Testicular Neoplasms × Olanzapine × Clear all
NCT05244577 2023-02-06

Olanzapine Combined With Fosaprepitant, Ondansetron, and Dexamethasone for Preventing Nausea and Vomiting in Patients With Testicular Cancer

Sun Yat-sen University

Phase 3 Unknown
75 enrolled
Genitourinary

Nausea, Testicular Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡